Most Read Articles
Popular Stories
RADAR on Medicare Advantage
-
As major publicly traded insurers reported third-quarter 2024 earnings results in recent weeks, familiar issues continued to impact select government players. For one, Medicaid managed care organizations are still...
-
Even as 2025 shapes up to be a year of service area reductions and product reshuffles, Medicare Advantage insurers are still making big investments in Special Needs Plans (SNPs). There are 137 net new...
HEALTH PLAN WEEKLY
-
During the UBS Global Healthcare Conference on Nov. 12, Elevance Health, Inc. Chief Financial Officer Mark Kaye attempted to reassure investors that the company is on the right track despite recent struggles...
-
With Donald Trump set to be the 47th president and Republicans in complete control of Congress, the fate of enhanced subsidies for Affordable Care Act exchange enrollees hangs in the balance. If these subsidies...
Radar On Speciality Pharmacy
-
Almost one year after the FDA put its approval decision on hold, Lilly has finally crossed the finish line with Ebglyss (lebrikizumab-lbkz). The approval means another option for the treatment of atopic dermatitis...
-
How the FDA fares during President-elect Donald Trump’s second term will depend, in part, on the pharmaceutical industry’s support for the agency and its staff, Commissioner Robert Califf told the Friends of...
RADAR ON DRUG BENEFITS
-
Copay maximizer programs are gaining popularity among payers while copay accumulators appear to be losing some of their appeal, according to the annual Copay Accumulator & Maximizer Programs Special Report...
-
Independent pharmacies have filed separate lawsuits against drug discount provider GoodRx and four of its partner PBMs, accusing the companies of a “conspiracy” to fix prices and suppress reimbursements to...
About AIS Health
AIS Health is a publishing and information company that has served the health care industry for more than 30 years. Our mission is to provide our readers with an actionable understanding of the business of health care and pharmaceuticals. Our in-depth writing covers the companies, people, catalysts and trends that create the richly textured contours of the health care and drug industry. AIS Health maintains journalistic independence from our parent company, MMIT. We are committed to integrity in reporting and bringing transparency to health industry data.
The Latest
Premium Categories
Premium Categories
Meet Our Reporters
Meet Our Reporters
Get an actionable understanding of the business of health care and pharmaceuticals
Sign up for publications to get unmatched business intelligence delivered to your inbox.